제2 형당뇨병약제치료지침2017 개정안: Glucagon-Like Peptide-1 수용체작용제.
김현진 - Journal of Korean Diabetes, 2018 - search.ebscohost.com
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a
monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the
position statement of the Korean Diabetes Association 2017 for pharmacological therapy …
monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the
position statement of the Korean Diabetes Association 2017 for pharmacological therapy …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论